• About us
• Contact

Advertisement

Collaboration › Details

Seagen–JPMorgan Chase: investor conference, 202101 supply service Seagen presents at JP Morgan Healthcare Conference 2021

 

	Period	2021-01-11
	Partner, 1st	Seagen Inc. (Nasdaq: SGEN)
	Group	Seagen (Group)
	Partner, 2nd	J.P. Morgan Securities LLC
	Group	JPMorgan Chase (Group)
	Product	J.P. Morgan 39th Annual Healthcare Conference 2021 DIGITAL
	Product 2	biopharmaceutical

Seagen Inc.. (12/16/20). "Press Release: Seagen to Present at the J.P. Morgan Healthcare Conference". Bothell, WA.

Seagen Inc. (Nasdaq: SGEN) today announced that management will present at the 39th Annual J.P. Morgan Virtual Healthcare Conference on Monday, January 11, 2021 at 2:00 p.m. Eastern Time. The presentation will be webcast live and available for replay from Seagen’s website at www.seagen.com in the Investors section.


About Seagen

Seagen is a global biotechnology company that discovers, develops and commercializes transformative cancer medicines to make a meaningful difference in people’s lives. Seagen is headquartered in the Seattle, Washington area, and has locations in California, Canada, Switzerland and the European Union. For more information on the company’s marketed products and robust pipeline, visit www.seagen.com and follow @SeagenGlobal on Twitter.


Peggy Pinkston
(425) 527-4160
ppinkston@seagen.com

Record changed: 2020-12-17

Advertisement

More documents for Seagen (Group)

• [1] Seagen Inc.. (3/13/23). "Press Release: Pfizer Invests $43 Billion to Battle Cancer. Pfizer to Acquire Seagen for $229 per Seagen Share in Cash". New York, NY & Bothell, WA....
• [2] Seagen Inc.. (11/10/22). "Press Release: Seagen Names David R. Epstein as Chief Executive Officer and Director". Bothell, WA....
• [3] Sanofi S.A.. (3/16/22). "Press Release: Sanofi and Seagen Announce Collaboration to Develop and Commercialize Multiple Novel Antibody-Drug Conjugates". Paris....
• [4] Seagen Inc.. (12/16/20). "Press Release: Seagen to Present at the J.P. Morgan Healthcare Conference". Bothell, WA....
• [5] Genmab A/S. (11/24/20). "Press Release: Genmab Announces Enapotamab Vedotin Update. Genmab Will Not Advance the Development of Enapotamab Vedotin". Copenhagen....
• [6] Seagen Inc.. (10/8/20). "Press Release: Seattle Genetics, Inc. Announces Corporate Name Change to Seagen Inc.". Bothell, WA....
• [7] BioClin Therapeutics, Inc.. (9/18/18). "Press Release: BioClin Therapeutics Announces New Leadership to Advance Late-Stage Bladder Cancer Development Program". San Leandro, CA....
• [8] Pieris Pharmaceuticals, Inc.. (3/9/18). "Press Release: Pieris Pharmaceuticals Reports Full-Year 2017 Financial Results and Corporate Update". Boston, MA....
• [9] PharmaMar S.A.. (2/14/18). "Press Release: PharmaMar Licenses Fully Synthetic Marine-derived Payloads to Seattle Genetics for Use in Drug Conjugates". Madrid....
• [10] Pieris Pharmaceuticals, Inc.. (2/9/18). "Press Release: Pieris Pharmaceuticals and Seattle Genetics Announce Multi-Program Immuno-Oncology Collaboration". Boston, MA & Bothell, WA....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.